Tumor Lysis Syndrome After Bilobectomy for Typical Carcinoid Tumor of the Lung

Thomas H Shin; Elica Inagaki; Teja Ganta; Kevan Hartshorn; Virginia R Litle; Kei Suzuki

doi:10.1016/j.athoracsur.2018.06.089

Tumor Lysis Syndrome After Bilobectomy for Typical Carcinoid Tumor of the Lung

Ann Thorac Surg. 2019 Mar;107(3):e199-e201. doi: 10.1016/j.athoracsur.2018.06.089. Epub 2018 Sep 12.

Authors

Thomas H Shin¹, Elica Inagaki¹, Teja Ganta², Kevan Hartshorn², Virginia R Litle¹, Kei Suzuki³

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Boston Medical Center, Boston, Massachusetts.
² Division of Hematology and Medical Oncology, Department of Medicine, Boston Medical Center, Boston, Massachusetts.
³ Division of Thoracic Surgery, Department of Surgery, Boston Medical Center, Boston, Massachusetts. Electronic address: kei.suzuki@bmc.org.

PMID: 30218665
DOI: 10.1016/j.athoracsur.2018.06.089

Abstract

Tumor lysis syndrome is a life-threatening complication comprising hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia attributed to release of intracellular contents. Although traditionally associated with leukemia and lymphoma after chemotherapy, it is known to occur in solid malignancies. We herein report a rare case of this syndrome after resection of bulky carcinoid tumor of the lung.

Publication types

Case Reports

MeSH terms

Carcinoid Tumor / diagnosis
Carcinoid Tumor / surgery*
Diagnosis, Differential
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / surgery*
Male
Middle Aged
Pneumonectomy / adverse effects*
Postoperative Complications*
Tomography, X-Ray Computed
Tumor Lysis Syndrome / diagnosis
Tumor Lysis Syndrome / etiology*